Aclaris Therapeutics, Inc. 4
4 · Aclaris Therapeutics, Inc. · Filed Dec 22, 2015
Insider Transaction Report
Form 4
Tullman Stephen A.
Director
Transactions
- Award
Stock option (right to buy)
2015-12-18+7,095→ 7,095 totalExercise: $28.68Exp: 2025-12-17→ Common Stock (7,095 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option will vest on December 18, 2016 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the reporting person's continued service with the issuer as of the applicable vesting date.